Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

Liver cancer cells cause stromal cells to secrete protein  that enhances tumor growth

Liver cancer cells cause stromal cells to secrete protein that enhances tumor growth

Study identifies biomarker gene signature that indicates potential liver toxicity

Study identifies biomarker gene signature that indicates potential liver toxicity

Non-invasive MRI technology helps improve surgical decision-making in liver cancer care

Non-invasive MRI technology helps improve surgical decision-making in liver cancer care

Combination therapy found to be effective against treatment-resistant hepatocellular carcinoma

Combination therapy found to be effective against treatment-resistant hepatocellular carcinoma

Novel targeted therapy blocks metabolic pathways in cancer cells with specific genetic defects

Novel targeted therapy blocks metabolic pathways in cancer cells with specific genetic defects

Scientists find significant differences in liver-related mortality rates in the U.S

Scientists find significant differences in liver-related mortality rates in the U.S

Study could pave the way for potential urine test to diagnose liver fibrosis

Study could pave the way for potential urine test to diagnose liver fibrosis

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Geography, household income impact liver cancer diagnoses and mortality

Geography, household income impact liver cancer diagnoses and mortality

Researchers develop new tool to improve the effectiveness of liver cancer outreach

Researchers develop new tool to improve the effectiveness of liver cancer outreach

Study highlights need for culturally relevant programs to educate Black communities on hepatitis B

Study highlights need for culturally relevant programs to educate Black communities on hepatitis B

Skoltech researchers identify new panel of potential biomarkers for liver cancer diagnosis

Skoltech researchers identify new panel of potential biomarkers for liver cancer diagnosis

Novel liver cancer treatment could shrink tumors in a mouse model

Novel liver cancer treatment could shrink tumors in a mouse model

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

Excessive fructose consumption can result in non-alcoholic fatty liver disease

Excessive fructose consumption can result in non-alcoholic fatty liver disease

Key molecule can be used to assess prognosis of triple negative breast cancer

Key molecule can be used to assess prognosis of triple negative breast cancer

Natural controllers shed light on immunity mechanisms against hepatitis B

Natural controllers shed light on immunity mechanisms against hepatitis B

European Commission approves first drug for hepatitis D

European Commission approves first drug for hepatitis D